e-learning
resources
Vienna 2012
Monday, 03.09.2012
Phenotypes and mechanisms of treatment of asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The inflammatory response of pulmonary vascular smooth muscle cells to bacterial endotoxin is sensitive to endothelin receptor antagonism
D. Jungck, M. Feldmann, C. Wahl, S. Koehler-Bachmann, C. Schindewolf, E. Stoelben, J. Behr, J. Knobloch, A. Koch (Bochum, Koeln, Germany)
Source:
Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Session:
Phenotypes and mechanisms of treatment of asthma
Session type:
Poster Discussion
Number:
1954
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Jungck, M. Feldmann, C. Wahl, S. Koehler-Bachmann, C. Schindewolf, E. Stoelben, J. Behr, J. Knobloch, A. Koch (Bochum, Koeln, Germany). The inflammatory response of pulmonary vascular smooth muscle cells to bacterial endotoxin is sensitive to endothelin receptor antagonism. Eur Respir J 2012; 40: Suppl. 56, 1954
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Role of airway smooth muscles in chronic airway inflammation and lung fibrosis and possible therapeutic potential of endothelin receptor antagonism
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010
Endothelin receptor antagonists (ERAs) neutralize LPS-induced cytokine release from pulmonary vascular smooth muscle cells (PVSMCs) by down-regulation of CD14
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Discrepant distribution of big endothelin (ET)-1 and ET receptors in the pulmonary artery
Source: Eur Respir J 2001; 18: 5-14
Year: 2001
Endothelin-1-induced airway and parenchymal mechanical responses in guinea-pigs: the roles of ETA and ETB receptors
Source: Eur Respir J 2001; 17: 975-981
Year: 2001
Muscarinic receptors augment TGF-β1 induced contractile protein and fibronectin expression in airway smooth muscle
Source: Annual Congress 2010 - Airway smooth muscle cells
Year: 2010
Role of interferons in endothelin-1 release from human pulmonary smooth muscle cells
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Increased expression of endothelin
B
receptors in the pulmonary arterial smooth muscle cells of fawn-hooded rat
Source: Eur Respir J 2001; 18: Suppl. 33, 416s
Year: 2001
Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Endothelin receptor B protects GM-CSF mRNA from degradation in human airway smooth muscle cells
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Role of purinergic receptors in the activation of human airway smooth muscle cells by the antimicrobial peptide LL-37
Source: Eur Respir J 2006; 28: Suppl. 50, 339s
Year: 2006
Role of purinergic receptors in the activation of human airway smooth muscle cells by the antimicrobial peptide LL-37
Source: Eur Respir Rev 2006; 15: 182-184
Year: 2006
Increased secretion of leukaemia inhibitory factor by immature airway smooth muscle cells enhances intracellular signalling and airway contractility
Source: Eur Respir J 2006; 28: Suppl. 50, 260s
Year: 2006
CCR2/CCR5-mediated macrophage–smooth muscle cell crosstalk in pulmonary hypertension
Source: Eur Respir J, 54 (4) 1802308; 10.1183/13993003.02308-2018
Year: 2019
Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism
Source: International Congress 2017 – Novel mechanisms and treatments for asthma
Year: 2017
Platelets induce airway smooth muscle cell proliferation through mechanisms dependent on ROS and 5-LOX metabolites
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005
Toll-like receptors mediating anti-viral responses cause direct and indirect activation of airway smooth muscle
Source: Eur Respir J 2005; 26: Suppl. 49, 345s
Year: 2005
The effect of estrogen and its receptor on hypoxic pulmonary vascular remodeling
Source: Eur Respir J 2006; 28: Suppl. 50, 658s
Year: 2006
Remicade suppresses cytokine-induced up-regulation of bradykinin receptor-mediated airway smooth muscle contractions
Source: Annual Congress 2005 - Inflammation and the airway smooth muscle: cellular and pharmacological interactions
Year: 2005
Effect of chronic stimulation of protease activating receptor-2 in human bronchial smooth muscle cells
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010
Targeting CCR2 and CCR5 to inhibit macrophage/pulmonary artery smooth muscle cells cross-talk in pulmonary hypertension
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept